The European Federation of Pharmaceutical Industries and Associations, which represents the research-based drugmakers in Europe, has called on the European Parliament "to make the Commission's proposals for safe, innovative and accessible medicines for European citizens a priority." The group's statement appeared on the day that Enterprise and Industry Commissioner Gunter Verheugen was due to meet with the Parliament's Health Committee for initial exchanges on the recently-launched Pharmaceutical Package (Marketletter December 15, 2008).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze